Follow
Daniel Lindén, PhD, Associate Professor
Daniel Lindén, PhD, Associate Professor
AstraZeneca CVMD IMED Bioscience Diabetes
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Opposing effects of adiponectin receptors 1 and 2 on energy metabolism
M Bjursell, A Ahnmark, M Bohlooly-Y, L William-Olsson, M Rhedin, ...
Diabetes 56 (3), 583-593, 2007
3492007
Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low–density lipoproteins
B Magnusson, L Asp, P Boström, M Ruiz, P Stillemark-Billton, D Lindén, ...
Arteriosclerosis, thrombosis, and vascular biology 26 (7), 1566-1571, 2006
1992006
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola, I Ahlstedt, AC Andréasson, ...
Molecular metabolism 22, 49-61, 2019
1792019
Selective inhibition of FOXO1 activator/repressor balance modulates hepatic glucose handling
F Langlet, RA Haeusler, D Lindén, E Ericson, T Norris, A Johansson, ...
Cell 171 (4), 824-835. e18, 2017
1722017
Activation of peroxisome proliferator-activated receptor α increases the expression and activity of microsomal triglyceride transfer protein in the liver
C Améen, U Edvardsson, A Ljungberg, L Asp, P Åkerblad, A Tuneld, ...
Journal of Biological Chemistry 280 (2), 1224-1229, 2005
1582005
Sex difference in hepatic peroxisome proliferator-activated receptor α expression: influence of pituitary and gonadal hormones
M Jalouli, L Carlsson, C Améen, D Lindén, A Ljungberg, L Michalik, ...
Endocrinology 144 (1), 101-109, 2003
1392003
the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
B Carlsson, D Lindén, G Brolén, M Liljeblad, M Bjursell, S Romeo, ...
Alimentary pharmacology & therapeutics 51 (12), 1305-1320, 2020
1382020
Liver‐directed overexpression of mitochondrial glycerol‐3‐phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid …
D Lindén, L William‐Olsson, A Ahnmark, K Ekroos, C Hallberg, ...
The FASEB journal 20 (3), 434-443, 2006
1382006
PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes
U Edvardsson, A Ljungberg, D Lindén, L William-Olsson, ...
Journal of lipid research 47 (2), 329-340, 2006
1142006
Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis
D Lindén, L William-Olsson, M Rhedin, AK Asztély, JC Clapham, ...
Journal of lipid research 45 (7), 1279-1288, 2004
1122004
Human multilineage 3D spheroids as a model of liver steatosis and fibrosis
P Pingitore, K Sasidharan, M Ekstrand, S Prill, D Lindén, S Romeo
International journal of molecular sciences 20 (7), 1629, 2019
1092019
Influence of peroxisome proliferator-activated receptor α agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48
D Lindén, K Lindberg, J Oscarsson, C Claesson, L Asp, L Li, ...
Journal of Biological Chemistry 277 (25), 23044-23053, 2002
1042002
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
S Prill, A Caddeo, G Baselli, O Jamialahmadi, P Dongiovanni, R Rametta, ...
Scientific reports 9 (1), 11585, 2019
1002019
An oral antisense oligonucleotide for PCSK9 inhibition
P Gennemark, K Walter, N Clemmensen, D Rekić, CAM Nilsson, ...
Science Translational Medicine 13 (593), eabe9117, 2021
882021
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
M Bohlooly-Y, B Olsson, CEG Bruder, D Lindén, K Sjogren, M Bjursell, ...
Diabetes 54 (1), 51-62, 2005
862005
PPARα deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins
D Lindén, M Alsterholm, H Wennbo, J Oscarsson
Journal of Lipid Research 42 (11), 1831-1840, 2001
842001
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
A Carreras, LS Pane, R Nitsch, K Madeyski-Bengtson, M Porritt, ...
BMC biology 17, 1-14, 2019
812019
Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH
M Bjursell, M Wedin, T Admyre, M Hermansson, G Böttcher, M Göransson, ...
PloS one 8 (5), e64721, 2013
792013
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice
F Frick, M Bohlooly-Y, D Lindén, B Olsson, J Törnell, S Edén, ...
American Journal of Physiology-Endocrinology and Metabolism 281 (6), E1230-E1239, 2001
742001
The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120
M Bjursell, X Xu, T Admyre, G Böttcher, S Lundin, R Nilsson, VM Stone, ...
PloS one 9 (12), e114942, 2014
722014
The system can't perform the operation now. Try again later.
Articles 1–20